0001372299-12-000003.txt : 20121126 0001372299-12-000003.hdr.sgml : 20121126 20121126133508 ACCESSION NUMBER: 0001372299-12-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20121126 DATE AS OF CHANGE: 20121126 EFFECTIVENESS DATE: 20121126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HISTOGENICS CORP CENTRAL INDEX KEY: 0001372299 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-181896 FILM NUMBER: 121223953 BUSINESS ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-457-7900 MAIL ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 D/A 1 primary_doc.xml X0706 D/A LIVE 0001372299 HISTOGENICS CORP 830 WINTER STREET WALTHAM MA MASSACHUSETTS 02451 781-457-7900 DELAWARE None None Corporation true Patrick O'Donnell c/o Histogenics Corporation 830 Winter Street, #3 Waltham MA MASSACHUSETTS 02451 Executive Officer Director Garheng Kong c/o Histogenics Corporation 830 Winter Street, #3 Waltham MA MASSACHUSETTS 02451 Director Joshua Baltzell c/o Histogenics Corporation 830 Winter Street, #3 Waltham MA MASSACHUSETTS 02451 Director Michael Lewis c/o Histogenics Corporation 830 Winter Street, #3 Waltham MA MASSACHUSETTS 02451 Director Kevin McArdle c/o Histogenics Corporation 830 Winter Street, #3 Waltham MA MASSACHUSETTS 02451 Executive Officer Kevin Rakin c/o Histogenics Corporation 830 Winter Street, #3 Waltham MA MASSACHUSETTS 02451 Director Biotechnology Decline to Disclose 06 true 0001372299-12-000002 2012-07-20 true true true true true In connection with the offering, the Company merged with Histogenics Finance Corporation, a Delaware corporation, with the Company continuing as the surviving entity. Such merger was effected solely for the purpose of reorganizing the Company's capital. 0 58286647 37638679 20647968 13 (a) and (b) include $6,250,000 attributed to the conversion of debt into shares of common stock and $2,786,647 attributed to the estimated value of the warrants. false 13 0 0 0 false HISTOGENICS CORP /s/ Kevin McArdle Kevin McArdle CFO and Treasurer 2012-11-21